Clinical Trial Update: Phase I/IIa Trial of scAAV1.tMCK.NTF3 for Treatment of CMT1A [Phase 1, Phase 2]

View source ↗

Summary

Phase I/IIa trial update of scAAV1.tMCK.NTF3 for Charcot-Marie-Tooth disease type 1A. The study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Charcot-marie-tooth Disease Type 1a

Drugs mentioned

• scAAV1.tMCK.NTF3

Snippet

Sponsor: Nationwide Children's Hospital | Conditions: Charcot-Marie-Tooth Neuropathy Type 1A | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING